Ken Griffin Boston Scientific Corp Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $2.48 Million - $2.95 Million	-43,000 Reduced 5.23%	778,800 $53.3 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $5.91 Million - $7.03 Million	121,600 Added 17.37%	821,800 $47.5 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $14.7 Million - $16 Million	291,900 Added 71.49%	700,200 $37 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $10.5 Million - $11.5 Million	-210,900 Reduced 34.06%	408,300 $22.1 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $2.82 Million - $3.13 Million	62,500 Added 11.23%	619,200 $31 Million

Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $3.41 Million - $4.07 Million	86,100 Added 18.3%	556,700 $25.8 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $3.56 Million - $10.6 Million	-97,000 Reduced 17.09%	470,600 $18.2 Million

1,320

1.17B

5.92M

5.75M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $111B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.